senate Bill S5150B

2019-2020 Legislative Session

Relates to prescribing an opioid antagonist with a patient's first opioid prescription each year

download bill text pdf

Sponsored By

Archive: Last Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (14)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Feb 04, 2020 referred to ways and means
delivered to assembly
passed senate
Feb 03, 2020 ordered to third reading cal.331
committee discharged and committed to rules
Jan 08, 2020 referred to health
Jun 20, 2019 recommitted to rules
Jun 19, 2019 ordered to third reading cal.1773
committee discharged and committed to rules
Jun 13, 2019 print number 5150b
Jun 13, 2019 amend and recommit to health
May 22, 2019 print number 5150a
May 22, 2019 amend (t) and recommit to health
Apr 11, 2019 referred to health

Votes

view votes

Feb 3, 2020 - Rules committee Vote

S5150B
16
0
committee
16
Aye
0
Nay
2
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Rules committee vote details

Jun 19, 2019 - Rules committee Vote

S5150B
18
0
committee
18
Aye
0
Nay
1
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

Co-Sponsors

S5150 - Details

See Assembly Version of this Bill:
A5603
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
S2966, A336

S5150 - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

S5150 - Sponsor Memo

S5150 - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5150

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                             April 11, 2019
                               ___________

Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, in  relation  to  prescribing  an
  opioid antagonist with a patient's first opioid analgesic prescription
  in a given year

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 3302 of the public health law is amended by  adding
two new subdivisions 44 and 45 to read as follows:
  44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
MORPHINE,  NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE, PROPOXYPHENE
AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
  45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN  PART  THE  PHARMACOLOGICAL
EFFECTS  OF  AN  OPIOID IN THE BODY. THE OPIOID ANTAGONIST IS LIMITED TO
NALOXONE OR OTHER  MEDICATIONS  APPROVED  BY  THE  DEPARTMENT  FOR  THIS
PURPOSE.
  §  2. Section 3309 of the public health law is amended by adding a new
subdivision 7 to read as follows:
  7. (A) WITH THE FIRST OPIOID ANALGESIC OF EACH  YEAR,  THE  PRESCRIBER
SHALL  PRESCRIBE  AN  OPIOID  ANTAGONIST  WHEN ANY OF THE FOLLOWING RISK
FACTORS ARE PRESENT: A HISTORY OF SUBSTANCE USE DISORDER; HIGH  DOSE  OR
CUMULATIVE  PRESCRIPTIONS  THAT  RESULT IN OVER FIFTY MORPHINE MILLIGRAM
EQUIVALENTS PER DAY; CONCURRENT USE OF  OPIOIDS  AND  BENZODIAZEPINE  OR
NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
  (B)  A  PRESCRIBER  WHO  FAILS  TO  PRESCRIBE AN OPIOID ANTAGONIST, AS
REQUIRED BY THIS SUBDIVISION,  SHALL  BE  REFERRED  TO  THE  APPROPRIATE
LICENSING  BOARD  SOLELY  FOR THE IMPOSITION OF ADMINISTRATIVE SANCTIONS
DEEMED APPROPRIATE BY SUCH  BOARD.  THIS  SECTION  SHALL  NOT  CREATE  A
PRIVATE  RIGHT  OF  ACTION  AGAINST  A  PRESCRIBER, AND DOES NOT LIMIT A

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

Co-Sponsors

S5150A - Details

See Assembly Version of this Bill:
A5603
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
S2966, A336

S5150A - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

S5150A - Sponsor Memo

S5150A - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5150--A

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                             April 11, 2019
                               ___________

Introduced by Sens. HARCKHAM, SALAZAR -- read twice and ordered printed,
  and when printed to be committed to the Committee on Health -- commit-
  tee  discharged, bill amended, ordered reprinted as amended and recom-
  mitted to said committee

AN ACT to amend the public health law, in  relation  to  prescribing  an
  opioid  antagonist  with  a  patient's  first opioid prescription in a
  given year

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1. Section 3309 of the public health law is amended by adding
a new subdivision 7 to read as follows:
  7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR  NURSING
HOME  UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI-
CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW, THE PRESCRIBER SHALL PRESCRIBE
AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOWING RISK FACTORS ARE PRESENT:
(A) A HISTORY OF SUBSTANCE USE DISORDER; (B)  HIGH  DOSE  OR  CUMULATIVE
PRESCRIPTIONS  THAT  RESULT IN OVER FIFTY MORPHINE MILLIGRAM EQUIVALENTS
PER DAY; (C) CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINE  OR  NONBENZO-
DIAZEPINE SEDATIVE HYPNOTICS.
  § 2. This act shall take effect on the one hundred eightieth day after
it  shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-
tation of this act on its effective date are authorized to be  made  and
completed  by  the  commissioner  of  health on or before such effective
date.


 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01771-08-9

Co-Sponsors

view additional co-sponsors

S5150B (ACTIVE) - Details

See Assembly Version of this Bill:
A5603
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
S2966, A336

S5150B (ACTIVE) - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

S5150B (ACTIVE) - Sponsor Memo

S5150B (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5150--B

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                             April 11, 2019
                               ___________

Introduced  by  Sens.  HARCKHAM,  CARLUCCI,  SALAZAR  --  read twice and
  ordered printed, and when printed to be committed to the Committee  on
  Health  --  committee  discharged,  bill amended, ordered reprinted as
  amended and recommitted to said  committee  --  committee  discharged,
  bill  amended,  ordered  reprinted  as amended and recommitted to said
  committee

AN ACT to amend the public health law, in  relation  to  prescribing  an
  opioid  antagonist  with  a  patient's  first opioid prescription in a
  given year

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1. Section 3309 of the public health law is amended by adding
a new subdivision 7 to read as follows:
  7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR  NURSING
HOME  UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI-
CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW,  OR  WHEN  A  PRACTITIONER  IS
PRESCRIBING  A  CONTROLLED  SUBSTANCE  TO  A  PATIENT  UNDER THE CARE OF
HOSPICE AS DEFINED BY SECTION FOUR THOUSAND TWO  OF  THIS  CHAPTER,  THE
PRESCRIBER  SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOW-
ING RISK FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE  USE  DISORDER;
(B)  HIGH  DOSE  OR  CUMULATIVE  PRESCRIPTIONS THAT RESULT IN OVER FIFTY
MORPHINE MILLIGRAM EQUIVALENTS PER DAY; (C) CONCURRENT  USE  OF  OPIOIDS
AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
  § 2. This act shall take effect on the one hundred eightieth day after
it  shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-
tation of this act on its effective date are authorized to be  made  and
completed  by  the  commissioner  of  health on or before such effective
date.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD01771-12-9

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.